Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-01-13

Clinical Trial Update: Amphotericin B Cholesteryl Sulfate Complex for Injection(ABCD) in the Treatment of Invasive Candidiasis and Invasive Aspergillosis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for Amphotericin B cholesteryl sulfate complex for injection (ABCD) in invasive candidiasis and invasive aspergillosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Amphotericin B cholesteryl sulfate complex for injection (ABCD) (Amphotericin B cholesteryl sulfate complex for injection)

Snippet

Sponsor: CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | Conditions: Invasive Candidiasis, Invasive Aspergillosis | Phase 2 | Status: UNKNOWN